64 related articles for article (PubMed ID: 19343544)
1. Time Trend Analysis of Splenectomy for Splenic Marginal Zone Lymphoma: Declining Surgery, Promising Survival.
Yang Z; Liu L; Leng K; Shi G
Ann Surg Oncol; 2023 Nov; 30(12):7206-7216. PubMed ID: 37516724
[TBL] [Abstract][Full Text] [Related]
2. A Rare Case of Synchronous Invasive Adenocarcinoma of the Colon and Marginal Zone Lymphoma of a Splenule Associated With Hemolytic Anemia.
Mukhopadhyay D; Sbitli T; Kishore A; Ilasin ER; Masood U
Cureus; 2024 Mar; 16(3):e55843. PubMed ID: 38590505
[TBL] [Abstract][Full Text] [Related]
3. The Role of Autoimmune Diseases in the Prognosis of Lymphoma.
Masciopinto P; Dell'Olio G; De Robertis R; Specchia G; Musto P; Albano F
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114226
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: A retrospective study.
Zhou JC; Wu MQ; Peng ZM; Zhao WH; Bai ZJ
Medicine (Baltimore); 2020 Feb; 99(7):e19015. PubMed ID: 32049797
[TBL] [Abstract][Full Text] [Related]
5. Recurrent autoimmune hemolytic anemia in splenic marginal zone lymphoma.
Oladiran O; Dhital R; Donato A
J Community Hosp Intern Med Perspect; 2018; 8(4):244-245. PubMed ID: 30181837
[TBL] [Abstract][Full Text] [Related]
6. [Clinical profile of autoimmune hemolytic anemia with monoclonal gammopathy IgMκ].
Huang ZD; Shi J; Shao YQ; Nie N; Zhang J; Li XX; Ge ML; Huang JB; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):233-7. PubMed ID: 27033762
[TBL] [Abstract][Full Text] [Related]
7. Splenectomy in older adults: indications and clinical outcomes.
Frasier LL; Malani PN; Diehl KM
Int J Hematol; 2013 Apr; 97(4):480-4. PubMed ID: 23443974
[TBL] [Abstract][Full Text] [Related]
8. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C; Felman P; Berger F; Dumontet C; Arnaud P; Hequet O; Arcache J; Callet-Bauchu E; Salles G; Coiffier B
Clin Lymphoma; 2002 Jun; 3(1):41-7. PubMed ID: 12141954
[TBL] [Abstract][Full Text] [Related]
9. [Splenic lymphoma, diagnosis and treatment].
Riller Q; Cohen-Aubart F; Roos-Weil D
Rev Med Interne; 2022 Oct; 43(10):608-616. PubMed ID: 35691756
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hemolytic anemia as a risk factor of poor outcome in patients with splenic marginal zone lymphoma.
Fodor A; Molnar MZ; Krenacs L; Bagdi E; Csomor J; Matolcsy A; Demeter J
Pathol Oncol Res; 2009 Dec; 15(4):597-603. PubMed ID: 19343544
[TBL] [Abstract][Full Text] [Related]
11. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
[TBL] [Abstract][Full Text] [Related]
12. [Splenic marginal zone lymphoma complicated by cold agglutinin disease].
Ochi K; Yokoyama K; Ohno N; Ota Y; Tojo A
Rinsho Ketsueki; 2017; 58(2):132-137. PubMed ID: 28321090
[TBL] [Abstract][Full Text] [Related]
13. No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab.
Kalpadakis C; Pangalis GA; Sachanas S; Rontogianni D; Korkolopoulou P; Milionis V; Vassilakopoulos TP; Papadaki HA; Angelopoulou MK
Leuk Lymphoma; 2016 Nov; 57(11):2705-8. PubMed ID: 27082039
[No Abstract] [Full Text] [Related]
14. Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
Bastidas-Mora G; Beà S; Navarro A; Gine E; Costa D; Delgado J; Baumann T; Magnano L; Rivas-Delgado A; Villamor N; Colomer D; Lopez-Guerra M; Rozman M; Balagué O; Martínez D; Baptista MJ; Escoda L; Alcoceba M; Blanes M; Climent F; Campo E; Wotherspoon A; López-Guillermo A; Matutes E
Br J Haematol; 2022 Jan; 196(1):146-155. PubMed ID: 34519021
[TBL] [Abstract][Full Text] [Related]
15. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
